By Karen Roman The Middleby Corp. (Nasdaq: MIDD) said net sales increased 15 percent in the first quarter to $840 million compared to the year prior. Adjusted EBITDA was $181 million in the quarter compared to $161 million a ;year...

By Daniella Parra Krispy Kreme, Inc. (Nasdaq: DNUT) said adjusted EBITDA rose 38 percent in the first quarter to $33.1 million from a year earlier amid a company turnaround. Net revenue fell 2.2 percent to $367 million, it said, adding...

By Karen Roman Shake Shack Inc. (NYSE: SHAK) said total revenue increased 14.3 percent in the first quarter to $366.7 million compared to the year prior. Shake Shack appointed Michelle Hook as Chief Financial Officer effective May 11, and opened...

By Daniella Parra Bob’s Discount Furniture, Inc. (NYSE: BOBS) said net revenue in the first quarter increased 8.5% to $578.1 million from a year earlier. Net income in the quarter was $41 million compared to $38.6 million a year earlier...

  By Daniella Parra Shift4 Payments, Inc. (NYSE: FOUR) said gross profit rose 54 percent to $370 million in the first quarter from a year earlier. The fintech company supports businesses across industries in more than 75 countries with Asia...

By Karen Roman NanoViricides, Inc. (NYSE: NNVC) said it will participate at the D. Boral Capital Global Conference, to be held on May 7, 2026, at The Plaza Hotel in New York City. The company’s President and Executive Chairman, Anil R....

By Karen Roman Vinson & Elkins said Will Myer has joined the firm’s Denver office as a Corporate Partner to strengthen its transactional platform, having previously been at WilmerHale. Mr. Myer has experience in strategic transactions like mergers and acquisitions,...

By Daniella Parra The ONE Group Hospitality, Inc. (Nasdaq: STKS) said first quarter operating income increased 30 percent as its asset-light expansion approach continues to gain traction. The company said it was on track to complete five Grill Concepts conversions...

By Karen Roman NanoViricides, Inc. (NYSE: NNVC) said the FDA granted “Orphan Drug Designation” (ODD) to its clinical-stage, antiviral drug NV-387 for the treatment of measles, giving the company seven years of market exclusivity after approval and access to tax...

By Karen Roman Portillo’s Inc. (Nasdaq: PTLO) said first quarter total revenue increased 3.5% to $182.6 million from a year earlier. Net loss was $0.5 million compared to net income of $4.0 million a year prior, and restaurant-level adjusted EBITDA...